IRIS
SANTORO, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.310
EU - Europa 2.523
AS - Asia 981
AF - Africa 324
SA - Sud America 96
OC - Oceania 36
Continente sconosciuto - Info sul continente non disponibili 6
Totale 8.276
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.193
DE - Germania 817
FR - Francia 564
CN - Cina 434
IT - Italia 389
GB - Regno Unito 183
IN - India 146
CA - Canada 82
CM - Camerun 81
ZA - Sudafrica 78
NL - Olanda 74
ES - Italia 67
RU - Federazione Russa 54
JP - Giappone 50
SE - Svezia 48
IE - Irlanda 45
UA - Ucraina 41
ID - Indonesia 37
DK - Danimarca 34
TR - Turchia 34
VN - Vietnam 33
AU - Australia 32
BE - Belgio 32
BR - Brasile 32
MX - Messico 29
HK - Hong Kong 28
PL - Polonia 28
CZ - Repubblica Ceca 27
AE - Emirati Arabi Uniti 25
KR - Corea 24
PK - Pakistan 24
TW - Taiwan 23
CH - Svizzera 22
KE - Kenya 22
IR - Iran 21
TH - Thailandia 21
CO - Colombia 18
EG - Egitto 17
ET - Etiopia 17
FI - Finlandia 17
UG - Uganda 16
CL - Cile 15
NG - Nigeria 15
MY - Malesia 14
PE - Perù 12
BW - Botswana 11
IL - Israele 11
SG - Singapore 11
TZ - Tanzania 11
AR - Argentina 10
LT - Lituania 10
PH - Filippine 10
PT - Portogallo 10
RS - Serbia 10
NO - Norvegia 8
BG - Bulgaria 7
SA - Arabia Saudita 7
AT - Austria 6
GH - Ghana 6
GR - Grecia 6
NA - Namibia 6
RO - Romania 6
DZ - Algeria 5
EC - Ecuador 5
IQ - Iraq 5
CD - Congo 4
CI - Costa d'Avorio 4
EU - Europa 4
GA - Gabon 4
ME - Montenegro 4
SR - Suriname 4
TG - Togo 4
AM - Armenia 3
BD - Bangladesh 3
CY - Cipro 3
JO - Giordania 3
MA - Marocco 3
NZ - Nuova Zelanda 3
PA - Panama 3
PS - Palestinian Territory 3
QA - Qatar 3
SK - Slovacchia (Repubblica Slovacca) 3
SL - Sierra Leone 3
SN - Senegal 3
ZW - Zimbabwe 3
AL - Albania 2
BJ - Benin 2
HU - Ungheria 2
LU - Lussemburgo 2
MK - Macedonia 2
MQ - Martinica 2
SY - Repubblica araba siriana 2
SZ - Regno dello Swaziland 2
ZM - Zambia 2
AP - ???statistics.table.value.countryCode.AP??? 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
LS - Lesotho 1
LV - Lettonia 1
ML - Mali 1
Totale 8.267
Salva come PNG Salva come JPEG
Città #
Woodbridge 854
Houston 600
Fairfield 279
Ashburn 207
Wilmington 193
Santa Cruz 180
Ann Arbor 172
Seattle 169
Buffalo 163
Cambridge 107
Rome 103
Beijing 92
University Park 83
Mountain View 60
Milan 53
Shanghai 53
Nürnberg 49
Dublin 43
Hangzhou 39
Los Angeles 35
Muizenberg 34
Guangzhou 32
Stockholm 32
Boardman 31
Chicago 31
Las Vegas 31
Leawood 30
Dong Ket 28
San Diego 28
Lyngby 26
Chongqing 24
Nanjing 22
Phoenix 20
Wuhan 20
Barcelona 19
London 18
Ottawa 18
Bengaluru 17
Jakarta 16
Nijmegen 16
Paris 15
Toronto 15
Clearwater 14
Riva 14
Council Bluffs 13
Dallas 13
Helsinki 13
Lausanne 13
Philadelphia 13
Central District 12
Durban 12
Mississauga 12
Chennai 11
Frankfurt am Main 11
Kampala 11
Nairobi 11
New York 11
Yaoundé 11
Cairo 10
Fremont 10
Henderson 10
San Francisco 10
Simi Valley 10
Tokyo 10
Zhengzhou 10
Catania 9
Florence 9
Hyderabad 9
Islamabad 9
Johannesburg 9
Lima 9
Madrid 9
Pittsburgh 9
Saint Petersburg 9
Xian 9
Athens 8
Baltimore 8
Detroit 8
Douala 8
Fort Lauderdale 8
Leuven 8
Mumbai 8
Rotterdam 8
Scranton 8
Taipei 8
Tel Aviv 8
Vancouver 8
Ankara 7
Atlanta 7
Buenos Aires 7
Cedar Knolls 7
Central 7
Delhi 7
Gaborone 7
Grenoble 7
Manchester 7
Santa Rosa 7
Tianjin 7
Glasgow 6
Hoppers Crossing 6
Totale 4.597
Salva come PNG Salva come JPEG
Nome #
Comet assay and micronucleus test in circulating erythrocytes of Cyprinus carpio specimens exposed in situ to lake waters treated with disinfectants for potabilization, file e291c0d3-f860-cddb-e053-3a05fe0aa144 771
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses, file e291c0d9-013b-cddb-e053-3a05fe0aa144 708
Interpretation of genotypic HIV-1 resistance to darunavir and virological response: validation of available systems and of a new score, file e291c0d5-62c0-cddb-e053-3a05fe0aa144 664
Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir-containing regimens., file e291c0d3-acbf-cddb-e053-3a05fe0aa144 590
Molecular Epidemiology of HIV Type 1 CRF02_AG in Cameroon and African Patients Living in Italy, file e291c0d3-ac93-cddb-e053-3a05fe0aa144 424
The future of long-acting cabotegravir plus rilpivirine therapy: deeds and misconceptions, file fd6ce3ef-f1a0-4efa-954f-0b7c38e4323c 348
Non-B HIV type 1 subtypes among men who have sex with men in Rome, Italy, file e291c0d3-ad05-cddb-e053-3a05fe0aa144 340
Efficacy of etravirine combined with darunavir or other ritonavir-boosted protease inhibitors in HIV-1-infected patients: An observational study using pooled European cohort data, file e291c0d4-c82b-cddb-e053-3a05fe0aa144 327
Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon, file e291c0d3-af60-cddb-e053-3a05fe0aa144 289
Lower prevalence of drug resistance mutations at first-line virological failure to first-line therapy with atripla vs. tenofovirRemtricitabine/lamivudineRefavirenz administered on a multiple tablet therapy, file e291c0d4-c9f3-cddb-e053-3a05fe0aa144 276
Circulation of HIV-1 CRF02_AG among MSM population in central Italy: a molecular epidemiology-based study, file e291c0d4-969e-cddb-e053-3a05fe0aa144 243
Improving the prediction of virological response to tipranavir: the development and validation of a tipranavir-weighted mutation score, file e291c0d3-ac89-cddb-e053-3a05fe0aa144 240
The lowest X4 Geno2Pheno false-positive rate is associated with greater CD4 depletion in HIV-1 infected patients, file e291c0d5-573d-cddb-e053-3a05fe0aa144 240
Impact of pre-therapy viral load on virological response to modern first-line HAART, file e291c0d5-5604-cddb-e053-3a05fe0aa144 236
'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing, file e291c0d3-ad19-cddb-e053-3a05fe0aa144 228
Baseline integrase drug resistance mutations and conserved regions across HIV-1 clades in Cameroon: implications for transition to dolutegravir in resource-limited settings, file e291c0d9-c1be-cddb-e053-3a05fe0aa144 228
The multifactorial pathways towards resistance to the cytosine analogues emtricitabine and lamivudine: Evidences from literature, file e291c0d4-95c2-cddb-e053-3a05fe0aa144 222
HIV-1 Genetic Variability and Clinical Implications, file e291c0d4-6daf-cddb-e053-3a05fe0aa144 212
Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14, file e291c0d6-ed1c-cddb-e053-3a05fe0aa144 212
The genotypic false positive rate determined by V3 population sequencing can predict the burden of HIV-1 CXCR4-using species detected by pyrosequencing, file e291c0d5-5fa5-cddb-e053-3a05fe0aa144 187
Alarming rates of virological failure and HIV-1 drug resistance amongst adolescents living with perinatal HIV in both urban and rural settings: evidence from the EDCTP READY-study in Cameroon, file e291c0d9-e6c9-cddb-e053-3a05fe0aa144 151
A very low geno2pheno false positive rate is associated with poor viro-immunological response in drug-naïve patients starting a first-line HAART., file e291c0d5-5f98-cddb-e053-3a05fe0aa144 150
Next-generation sequencing provides an added value in determining drug resistance and viral tropism in Cameroonian HIV-1 vertically infected children, file e291c0d7-0b62-cddb-e053-3a05fe0aa144 146
Virological response and resistance profile in highly treatment-experienced HIV-1-infected patients switching to dolutegravir plus boosted darunavir in clinical practice, file e291c0d9-c157-cddb-e053-3a05fe0aa144 109
Clinical relevance of genotypic resistance testing today, file e291c0d5-e25e-cddb-e053-3a05fe0aa144 103
The Lowest X4 Geno2Pheno-False Positive Rate Is Associated with Greater CD4-Depletion, file e291c0d3-ee2d-cddb-e053-3a05fe0aa144 89
Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: A multicentre retrospective cohort study, file e291c0d8-3229-cddb-e053-3a05fe0aa144 88
An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim Project, file e291c0d5-8dae-cddb-e053-3a05fe0aa144 86
Impact of pre-existent drug resistance on virological efficacy of single tablet regimens in people living with HIV, file c8db3222-eab2-46bf-a88f-3c6165c7ccb0 83
Viral suppression in adults, adolescents and children receiving antiretroviral therapy in Cameroon: Adolescents at high risk of virological failure in the era of "test and treat", file e291c0d8-7024-cddb-e053-3a05fe0aa144 81
Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration, file e291c0d8-67a0-cddb-e053-3a05fe0aa144 78
Genotypic HIV-1 tropism determination might help to identify people with exhausted treatment options and advanced disease, file e291c0d9-da22-cddb-e053-3a05fe0aa144 74
Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile, file 84dab908-161c-49c1-a9ee-ecf983c9f7fe 73
Dolutegravir-Based Regimen Ensures High Virological Success despite Prior Exposure to Efavirenz-Based First-LINE ART in Cameroon: An Evidence of a Successful Transition Model, file fcb98d47-6d3e-4b5f-a0d5-57c38addde92 71
Genetic divergence of HIV-1 B subtype in Italy over the years 2003–2016 and impact on CTL escape prevalence, file e291c0d8-9a36-cddb-e053-3a05fe0aa144 48
Evaluation of virological response and resistance profile in HIV-1 infected patients starting a first-line integrase inhibitor-based regimen in clinical settings, file e291c0d9-8984-cddb-e053-3a05fe0aa144 44
HIV-1 Gag gene mutations, treatment response and drug resistance to protease inhibitors: a systematic review and meta-analysis protocol, file e291c0d9-bff1-cddb-e053-3a05fe0aa144 29
Impact of analytical treatment interruption on burden and diversification of HIV peripheral reservoir: a pilot study, file e291c0d9-e132-cddb-e053-3a05fe0aa144 28
Bictegravir/emtricitabine/tenofovir alafenamide ensures high rates of virological suppression maintenance despite previous resistance in PLWH who optimize treatment in clinical practice, file 04789885-fbb5-4003-bca4-6525775400a9 27
Evaluation of HIV-1 integrase variability by combining computational and probabilistic approaches, file 3467ed63-f331-4fcb-a9f8-55b5c646c1fa 26
What Are the Effects of Vitamin A Oral Supplementation in the Prevention and Management of Viral Infections? A Systematic Review of Randomized Clinical Trials, file 0c4d75da-eca2-4992-852e-bc6f2cb91fae 25
HIV-1 integrase resistance associated mutations and the use of dolutegravir in Sub-Saharan Africa: a systematic review and meta-analysis protocol, file e291c0d9-7f29-cddb-e053-3a05fe0aa144 13
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses, file 32b8fdbc-cc97-4bb2-b323-db5ad2f22570 12
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels, file e291c0d8-a91f-cddb-e053-3a05fe0aa144 6
Frequency of atypical mutations in the spike glycoprotein in SARS-CoV-2 circulating from July 2020 to July 2022 in central Italy: a refined analysis by Next Generation Sequencing, file 52761ed5-cb6a-4f94-bf88-6c4213eafea1 5
The HIV-1 reverse transcriptase polymorphism A98S improves the response to tenofovir disoproxil fumarate + emtricitabine-containing HAART both in vivo and in vitro, file e291c0d6-424a-cddb-e053-3a05fe0aa144 4
Residual phenotypic susceptibility to doravirine in multidrug-resistant HIV-1 from subjects enrolled in the PRESTIGIO Registry, file 86f0c706-bb92-4a59-93c4-21e297028ad5 2
Short communication: Population-based surveillance of HIV-1 drug resistance in cameroonian adults initiating antiretroviral therapy according to the world health organization guidelines, file e291c0d5-8a65-cddb-e053-3a05fe0aa144 2
High Burden of HBV-Infection and Atypical HBV Strains among HIV-infected Cameroonians, file e291c0d5-d561-cddb-e053-3a05fe0aa144 2
Laboratory Based Surveillance of HIV-1 Acquired Drug Resistance in Cameroon: Implications for Use of Tenofovir-Lamivudine-Dolutegravir (TLD) as Second- or Third-Line Regimens, file 3faf1f14-bbde-4a80-9713-e061d3937510 1
Genotypic Resistance Testing of HIV-1 DNA in Peripheral Blood Mononuclear Cells, file 41fcc4bb-b5fb-48c1-b9be-0bd77c144192 1
Viral resistance burden and APOBEC editing correlate with virological response in heavily treatment-experienced people living with multi-drug resistant HIV, file 42785d23-725c-4f00-86cf-f2f2474ef0d2 1
Inflammation burden score in multidrug-resistant HIV-1 infection, file c0aa3617-de4a-4d30-9f30-e3fd7da00b32 1
Evaluation of HIV-DNA and residual viremia levels through week 96 in HIV-infected individuals who continue a two-drug or switch to a three-drug integrase strand transfer inhibitor-based regimen, file daf0d258-c878-4421-9cd6-ed2782ce2859 1
Structural modifications induced by specific HIV-1 protease-compensatory mutations have an impact on the virological response to a first-line lopinavir/ritonavir-containing regimen, file e291c0d5-9631-cddb-e053-3a05fe0aa144 1
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen, file e291c0d8-a6dc-cddb-e053-3a05fe0aa144 1
Rare occurrence of doravirine resistance-associated mutations in HIV-1-infected treatment-naive patients, file e291c0d8-e169-cddb-e053-3a05fe0aa144 1
Totale 8.648
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.980
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.980
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019333 0 0 0 0 0 0 0 0 0 0 162 171
2019/20201.018 145 87 59 83 83 98 93 74 97 79 66 54
2020/20211.044 51 82 69 71 59 71 88 84 86 136 115 132
2021/20221.484 130 125 100 256 200 52 61 52 105 63 212 128
2022/20231.167 53 96 199 130 89 102 113 73 76 64 108 64
2023/20241.389 107 111 124 64 125 71 311 243 159 74 0 0
Totale 8.648